PRKCA and intervertebral disk degenerative disorder: By targeting PRKCA, tsRNA-04002 inhibits the expression of IL-1β and TNF-α and modulates the MAPK signaling pathway, thus suppressing nucleus pulposus cell apoptosis and mitigating IDD [37287061].